STIM: Enhancing Brain Health by tDCS in Persons With Overweight and Obesity

Sponsor
University Hospital Tuebingen (Other)
Overall Status
Recruiting
CT.gov ID
NCT05228067
Collaborator
(none)
40
1
3
24.7
1.6

Study Details

Study Description

Brief Summary

Disturbances in the hypothalamus communication pathways with other regions in the brain and the periphery may represent a potential link between metabolic and cognitive health. The current project evaluates whether enhancing synaptic plasticity of this pathway can improve weight management, insulin sensitivity, and cognitive functions. In recent studies, we were able to show that the human brain is sensitive to insulin with favorable effects on peripheral metabolism and cognition. These brain regions encompass the hypothalamus and its connections to the striatum and prefrontal cortex. We want to investigate whether it is possible to enhance neuroplasticity of insulin-responsive brain regions to suppress the weight gain trajectory and improve dopamine-dependent cognitive functions in people with a high risk to develop type 2 diabetes. For this purpose, neuroimaging tools using high-definition transcranial direct current stimulation (HD-tDCS) and magnetic resonance imaging (MRI) will be implemented to assess synaptic plasticity of a neural network essential for metabolic and cognitive health.

Condition or Disease Intervention/Treatment Phase
  • Device: anodal transcranial direct current stimulation
  • Device: cathodal transcranial direct current stimulation
  • Device: sham transcranial direct current stimulation
N/A

Detailed Description

The overarching aim of the study is to investigate the possibility to enhance neuroplasticity of the hypothalamus network to improve metabolism and dopamine-dependent cognitive functions.

Specific objectives

  • Specifically, it is the first aim to study the predictive value of white matter microstructure (fiber tracts structurally connecting the target network) for tDCS-intervention response and to investigate tDCS-induced neuroplasticity changes of the hypothalamus brain network using functional magnetic resonance imaging (fMRI).

  • It is the second aim of this study to deepen our understanding of brain structure and function of the target network, which is known to rely on the neurotransmitter dopamine for its communication. Hence, we will use dopamine-dependent cognitive and eating behavior assessments.

Participants will receive a thorough screening to obtain body composition by MRI, anthropometric measures, fasting glucose and insulin, indirect calorimetry, and general cognitive functions. Thereafter, participants will participate in three measurement days (separated by approx. one week) to receive a 25 min tDCS stimulation targeting the hypothalamus network in a double-blind cluster-randomized. Participant are randomized on three conditions: sham stimulation, anodal and cathodal stimulation. During the non-invasive brain stimulation, participants will perform a stop-signal task. On each measurement day, structural and functional MRI measurements are performed before and after stimulation. Dopamine-dependent behavior (i.e. reward task) will be assessed during fMRI measurement. Subsequently, participants will receive a breakfast buffet. The caloric intake from fat, carbohydrates and protein will be documented. Subjective feeling of hunger and food craving will be assessed using a visual analogue scale before stimulation, directly after stimulation and after breakfast. Food pictures will be rated on a laptop for taste and healthiness.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
All participants receive sham stimulation, anodal stimulation and cathodal stimulation in a pseudo-randomized order on three separate measurement days.All participants receive sham stimulation, anodal stimulation and cathodal stimulation in a pseudo-randomized order on three separate measurement days.
Masking:
Double (Participant, Investigator)
Masking Description:
Stimulation protocol is applied in a double blind fashion.
Primary Purpose:
Basic Science
Official Title:
Enhancing Brain Health to Prevent Type 2 Diabetes
Actual Study Start Date :
Nov 8, 2021
Anticipated Primary Completion Date :
Jun 1, 2023
Anticipated Study Completion Date :
Dec 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Anodal stimulation

Anodal tDCS of the hypothalamus network

Device: anodal transcranial direct current stimulation
anodal tDCS of the hypothalamus resting-state functional connectivity network using 12 Electrodes of the Starstim device by Neuroelectrics. The total injected current will never go beyond 4 milliamp, which will be split among the different stimulation electrodes.
Other Names:
  • anodal tDCS
  • excitatory tDCS
  • Active Comparator: Cathodal stimulation

    Cathodal tDCS of the hypothalamus network

    Device: cathodal transcranial direct current stimulation
    anodal tDCS of the hypothalamus resting-state functional connectivity network using 12 Electrodes of the Starstim device by Neuroelectrics. The total injected current will never go beyond 4 milliamp, which will be split among the different stimulation electrodes.
    Other Names:
  • cathodal tDCS
  • inhibitory tDCS
  • Sham Comparator: Sham stimulation

    Sham tDCS of the hypothalamus network

    Device: sham transcranial direct current stimulation
    Double blind sham stimulation of the hypothalamus resting-state functional connectivity network (ramp-up ramp-down stimulation will be applied for 30 seconds)
    Other Names:
  • sham tDCS
  • Outcome Measures

    Primary Outcome Measures

    1. Change in neuroplasticity [20 min directly before and after tDCS stimulation]

      Fractional anisotropy (FA) of the target network

    2. Change in functional connectivity [20 min directly before and after tDCS stimulation]

      Resting state functional connectivity of the target network

    3. Change in eating behavior [1 hour after tDCS stimulation]

      Caloric intake (kcal), Free-choice, ad libitum food intake from a standardized breakfast buffet. The caloric intake from fat, carbohydrates and protein will be documented

    4. Change in dopamine-dependent cognitive function [20 minutes after tDCS stimulation]

      Changes in dopamine-dependent cognitive function and reward sensitivity measured by a reward-based decision-making task

    Secondary Outcome Measures

    1. Change in subjective ratings [5 minutes before tDCS stimulation, 5 minutes after tDCS stimulation and 5 minutes after buffet]

      Change in subjective ratings will be assessed using a visual analogue scale for hunger and subjective feeling of craving using a questionnaire (Food craving questionnaire). Visual analogue scale using a range from 0 to 10 cm, higher values indicating more hunger. Food craving questionnaire based on ordinal scale from 1 to 5, higher values indicating more food craving

    2. Performance during stop-signal task [task is performed during 25-minutes tDCS stimulation]

      Outcome measures cover direction errors, proportion of successful stops, reaction time on Go trials, and stop signal reaction time (SSRT)

    3. Tastiness and healthiness rating of food stimuli [task is performed immediately after buffet]

      Using a computer based task, participants rate food pictures of low caloric and high caloric foods and snacks on a 5-point scale based on subjective tastiness and healthiness

    4. Food choice [task is performed immediately after buffet]

      Using a computer based task, participants have to choose food items they preferred to eat compared to a reference food on a 5-point choice scale. The reference (or "neutral") food item is individually determined based the health and taste rating [Scale: 1= not tasty/ not healthy up to 5= very tasty/ very healthy]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    20 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Written consent to participate in the study

    • Written consent to be informed about incidental findings

    Overweight and obese participants:
    • Body mass index (BMI) between 28 and 39.5 kg/m2

    • Age between 20 to 65 years of age

    • Waist circumference > 80 cm for women, > 94 cm for men

    Sex and age matched normal weight individuals:
    • Body mass index (BMI) between 19.5 and 24.5 kg/m2

    • Age between 20 to 65 years of age

    Exclusion Criteria:
    • Insufficient knowledge of the German language

    • Persons who cannot legally give consent

    • Pregnancy or lactation

    • History of severe mental or somatic disorders including neurological diseases (incl. Epileptic seizures)

    • Taking psychotropic drugs

    • Previous bariatric surgery

    • Acute infection within the last 4 weeks

    • Hemoglobin values less than 12g/dl for women, less than 14 g/dl for men

    • Current participation in a lifestyle intervention study or a pharmaceutical study

    • Contradictions to a MRI measurement (e.g. metal implants)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University Clinic Tübingen Tübingen Germany 72076

    Sponsors and Collaborators

    • University Hospital Tuebingen

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital Tuebingen
    ClinicalTrials.gov Identifier:
    NCT05228067
    Other Study ID Numbers:
    • 172/2021BO1
    First Posted:
    Feb 8, 2022
    Last Update Posted:
    Feb 8, 2022
    Last Verified:
    Nov 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University Hospital Tuebingen
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 8, 2022